Who Owns Invesco Biotechnology & Genome ETF (PBE)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$8.000000553300031e+254T
% of Float Held
—
QoQ Change in Holders
+11 / -3
Price History
PBE — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | Increased | +2K | +$4.0B |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | Increased | +17K | +$2.1B |
| Penobscot Investment Management Company, Inc. | New Position | +19K | +$1.6B |
| Massachusetts Wealth Management | New Position | +18K | +$1.5B |
| COMMONWEALTH EQUITY SERVICES, LLC | New Position | +22K | +$1.0B |
| INVESTMENT HOUSE LLC | New Position | +9K | +$704.0M |
| FLAGSHIP HARBOR ADVISORS, LLC | New Position | +5K | +$418.0M |
| YHB Investment Advisors, Inc. | Increased | +95 | +$305.1M |
| Stratos Wealth Partners, LTD. | New Position | +3K | +$260.0M |
| Joel Isaacson & Co., LLC | New Position | +3K | +$248.0M |
| Sowell Financial Services LLC | New Position | +3K | +$244.0M |
| Wharton Business Group, LLC | New Position | +3K | +$225.0M |
| BOS Asset Management, LLC | New Position | +2K | +$200.0M |
| Millstone Evans Group, LLC | New Position | +2K | +$146.0M |
| Farther Finance Advisors, LLC | Increased | +100 | +$113.8M |
PBE — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| Gerber Kawasaki Wealth & Investment Management | Decreased | -3K | -$3.2B |
| CreativeOne Wealth, LLC | Decreased | -532 | -$832.6M |
| One Capital Management, LLC | Decreased | -513 | -$711.9M |
| OSAIC HOLDINGS, INC. | Decreased | -452 | -$646.1M |
| STIFEL FINANCIAL CORP | Decreased | -430 | -$477.9M |
| VestGen Advisors, LLC | Decreased | -2K | -$327.3M |
| Hills Bank & Trust Co | Decreased | -88 | -$324.3M |
| ROYAL BANK OF CANADA | Decreased | -289 | -$312.0M |
| WELLS FARGO & COMPANY/MN | Decreased | -330 | -$296.9M |
| GOLDMAN SACHS GROUP INC | Decreased | -93 | -$258.5M |
| Dakota Wealth Management | Closed Position | -3K | -$223.6M |
| Creative Planning | Decreased | -55 | -$220.8M |
| CITADEL ADVISORS LLC | Closed Position | -3K | -$206.3M |
| GeoWealth Management, LLC | Decreased | -611 | -$183.1M |
| Glenmede Investment Management, LP | Closed Position | -2K | -$130.0M |
Top Institutional Holders(Q4 2025)
PBE Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 108 | $37.1B | +39 |
| Q3 2025 | 69 | $45.2B | -16 |
| Q2 2025 | 85 | $61.4B | -9 |
| Q1 2025 | 94 | $79.4B | +5 |
| Q4 2024 | 89 | $706.0B | +8 |
| Q3 2024 | 81 | $25.7T | +0 |
| Q2 2024 | 81 | $22.7T | +2 |
| Q1 2024 | 79 | $222.6T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold PBE (Invesco Biotechnology & Genome ETF). The largest holder is UNITED CAPITAL FINANCIAL ADVISORS, LLC with $8.0B in shares. This quarter, 11 institutions opened new positions and 3 closed their positions.
Frequently Asked Questions
How many hedge funds own PBE?
As of Q4 2025, 50 institutional investors report holding PBE (Invesco Biotechnology & Genome ETF) in their 13F filings.
Who is the largest institutional holder of PBE?
The largest institutional holder of PBE is UNITED CAPITAL FINANCIAL ADVISORS, LLC with $8.0B in shares.
Is institutional ownership of PBE increasing or decreasing?
This quarter, 11 institutions opened new positions in PBE and 3 closed their positions.